Issue 2/2015
Content (22 Articles)
Active and passive smoking and risk of breast cancer: a meta-analysis
Alina Macacu, Philippe Autier, Mathieu Boniol, Peter Boyle
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer
Andrew Ciupek, Yassine Rechoum, Guowei Gu, Luca Gelsomino, Amanda R. Beyer, Lauren Brusco, Kyle R. Covington, Anna Tsimelzon, Suzanne A. W. Fuqua
Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy
Shiwei Liu, Xuening Duan, Ling Xu, Ling Xin, Yuanjia Cheng, Qian Liu, Jingming Ye, Shuang Zhang, Hong Zhang, Sainan Zhu, Ting Li, Yinhua Liu
Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer
Neha Aggarwal, Ann Marie Santiago, David Kessel, Bonnie F. Sloane
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover
Steffi Oesterreich, N. Lynn Henry, Kelley M. Kidwell, Catherine H. Van Poznak, Todd C. Skaar, Jessica Dantzer, Lang Li, Thomas N. Hangartner, Munro Peacock, Anne T. Nguyen, James M. Rae, Zeruesenay Desta, Santosh Philips, Anna M. Storniolo, Vered Stearns, Daniel F. Hayes, David A. Flockhart
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Meredith M. Regan, Olivia Pagani, Prudence A. Francis, Gini F. Fleming, Barbara A. Walley, Roswitha Kammler, Patrizia Dell’Orto, Leila Russo, János Szőke, Franco Doimi, Laura Villani, Stefano Pizzolitto, Christian Öhlschlegel, Fausto Sessa, Vicente Peg Cámara, José Luis Rodríguez Peralto, Gaëtan MacGrogan, Marco Colleoni, Aron Goldhirsch, Karen N. Price, Alan S. Coates, Richard D. Gelber, Giuseppe Viale
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor
Kimberly Blackwell, Howard Burris, Patricia Gomez, N. Lynn Henry, Steven Isakoff, Frank Campana, Lei Gao, Jason Jiang, Sandrine Macé, Sara M. Tolaney
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score
Denise A. Yardley, Nancy W. Peacock, Mythili Shastry, Howard A. Burris III, Rebecca G. Bechhold, Carolyn B. Hendricks, Carl N. Yoshizawa, Amy P. Sing, John D. Hainsworth
Dose–response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial
Kathryn H. Schmitz, Nancy I. Williams, Despina Kontos, Susan Domchek, Knashawn H. Morales, Wei-Ting Hwang, Lorita L. Grant, Laura DiGiovanni, Domenick Salvatore, Desire’ Fenderson, Mitchell Schnall, Mary Lou Galantino, Jill Stopfer, Mindy S. Kurzer, Shandong Wu, Jessica Adelman, Justin C. Brown, Jerene Good
A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up
Jamie M. Stagl, Suzanne C. Lechner, Charles S. Carver, Laura C. Bouchard, Lisa M. Gudenkauf, Devika R. Jutagir, Alain Diaz, Qilu Yu, Bonnie B. Blomberg, Gail Ironson, Stefan Glück, Michael H. Antoni
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors
Wendy Demark-Wahnefried, Graham A. Colditz, Cheryl L. Rock, Rebecca L. Sedjo, Jingxia Liu, Kathleen Y. Wolin, Helen Krontiras, Tim Byers, Bilgé Pakiz, Barbara A. Parker, Michael Naughton, Anthony Elias, Patricia A. Ganz
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Jin Sun Lee, Michelle E. Melisko, Mark Jesus M. Magbanua, Andrea T. Kablanian, Janet H. Scott, Hope S. Rugo, John W. Park
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer
Antonio Llombart-Cussac, Begoña Bermejo, Cristian Villanueva, Suzette Delaloge, Serafín Morales, Judith Balmaña, Kepa Amillano, Hervé Bonnefoi, Ana Casas, Luis Manso, Henri Roché, Santiago Gonzalez-Santiago, Joaquín Gavilá, Pedro Sánchez-Rovira, Serena Di Cosimo, Nadia Harbeck, Eric Charpentier, Ignacio Garcia-Ribas, Nina Radosevic-Robin, Claudia Aura, Jose Baselga
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors
Adrienne G. Waks, Sara M. Tolaney, Alicia Galar, Amal Arnaout, Julie B. Porter, Francisco M. Marty, Eric P. Winer, Sarah P. Hammond, Lindsey R. Baden
Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden
Jianguang Ji, Bengt Zöller, Amato Giaccia, Robert Haile, Jan Sundquist, Kristina Sundquist
Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection
Anna M. Chiarelli, Maegan V. Prummel, Derek Muradali, Rene S. Shumak, Vicky Majpruz, Patrick Brown, Hedy Jiang, Susan J. Done, Martin J. Yaffe
Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Cecilie Kyrø, Raul Zamora-Ros, Augustin Scalbert, Anne Tjønneland, Laure Dossus, Christoffer Johansen, Pernille Envold Bidstrup, Elisabete Weiderpass, Jane Christensen, Heather Ward, Dagfinn Aune, Elio Riboli, Mathilde His, Françoise Clavel-Chapelon, Laura Baglietto, Verena Katzke, Tilman Kühn, Heiner Boeing, Anna Floegel, Kim Overvad, Cristina Lasheras, Noémie Travier, Maria-José Sánchez, Pilar Amiano, Maria-Dolores Chirlaque, Eva Ardanaz, Kay-Tee Khaw, Nick Wareham, Aurora Perez-Cornago, Antonia Trichopoulou, Pagona Lagiou, Effie Vasilopoulou, Giovanna Masala, Sara Grioni, Franco Berrino, Rosario Tumino, Carlotta Sacerdote, Amalia Mattiello, H. B(as). Bueno-de-Mesquita, Petra H. Peeters, Carla van Gils, Signe Borgquist, Salma Butt, Anne Zeleniuch-Jacquotte, Malin Sund, Anette Hjartåker, Guri Skeie, Anja Olsen, Isabelle Romieu
Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program
Marisa Baré, Núria Torà, Dolores Salas, Melchor Sentís, Joana Ferrer, Josefa Ibáñez, Raquel Zubizarreta, Garbiñe Sarriugarte, Teresa Barata, Laia Domingo, Xavier Castells, Maria Sala
Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer
Cathy J. Bradley, Bassam Dahman, Reshma Jagsi, Steven Katz, Sarah Hawley
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Lei Zhang, Ye Xu, Xingyu Jin, Zengwu Wang, Yidi Wu, Deyao Zhao, Gang Chen, Deyu Li, Xiaoxia Wang, Huiqing Cao, Yuntao Xie, Zicai Liang
Confocal laser endomicroscopy in breast surgery
Giovanni D. De Palma, Gaetano Luglio, Dario Esposito